Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × veliparib × 90 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Breast Neoplasms 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioblastoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡